COMMUNIQUÉS West-GlobeNewswire

Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
10/02/2026
SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
The Cooperative of American Physicians Announces Continued A+ (Superior) Rating for the Mutual Protection Trust
10/02/2026
Rating reaffirmed for the 19th consecutive year, reflecting long-term financial stability LOS ANGELES, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The Cooperative of American Physicians, Inc. (CAP) announced that AM Best has [...]
PharmAla Announces Changes to Board of Directors
10/02/2026
TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Neuronetics Announces Selected Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
10/02/2026
All values provided represent preliminary unaudited results Fourth quarter 2025 revenue of $41.8 million, representing 86% year-over-year growth on an as reported basis and 23% year-over-year growth on an adjusted pro [...]
Blueroot Health Appoints Jay Schwartz CEO as North Castle Backs Next Phase of Practitioner-Focused Growth
10/02/2026
MIDDLETOWN, Conn., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Blueroot Health , a consumer health company focused on advancing long-term health and well-being for people and the planet, today announced the appointment of Jay [...]
DBV Technologies présentera des données complémentaires issues de l'étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans et discutera de l'avenir de l'EPIT lors du congrès annuel 2026 de l'AAAAI
10/02/2026
Châtillon, France, le 10 février (22 :30 CET) 2026 DBV Technologies présentera des données complémentaires issues de l'étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans et [...]
Upstream Bio to Host Webcast to Report Top-Line Results from the Phase 2 VALIANT Trial of Verekitug in Patients with Severe Asthma
11/02/2026
– Webcast to be held Wednesday, February 11, 2026, at 8:00 a.m. ET – WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory [...]
Miami Startup Launches First At-Home Gut Test Designed Specifically for Cognitive Wellness
10/02/2026
Cervco's Gut-Brain Wellness Test helps adults monitor bacteria and lifestyle factors that research links to cognitive wellness—no doctor's prescription required MIAMI, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Cervco, a [...]
Newsweek Names Chicago Plastic Surgeons Best in America for 11 Procedures
10/02/2026
CHICAGO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Board-certified plastic surgeons Thomas Mustoe, MD , and Sammy Sinno, MD , of TLKM Plastic Surgery, have been recognized by Newsweek as two of America’s Best Plastic Surgeons [...]
Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation
10/02/2026
Approval Marks Final Regulatory Milestone Required to Enable Launch of Upstream Manufacturing Activities Under New Offshored & Outsourced Production Model Expected to Drive Gross Margin Expansion, Improve Working [...]
Nebraska Remains a National Outlier in Certified Nurse-Midwife Regulation
10/02/2026
Examining Nebraska’s Certified Nurse-Midwife regulations following stalled legislative reform LINCOLN, NE,, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Nebraska regulates Certified Nurse-Midwives differently than nearly every [...]
Communiqué de presse : Sanofi finalise l’acquisition de Dynavax
10/02/2026
Sanofi finalise l’acquisition de Dynavax Paris, le 10 février 2026. Sanofi a annoncé aujourd’hui avoir finalisé l’ acquisition de Dynavax Technologies Corporation (Dynavax). L’acquisition comprend le vaccin contre l’ [...]
IBA – ACQUISITION OF OWN SHARES
10/02/2026
Louvain-la-Neuve, Belgium, February 10 th , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA [...]
Hassan Spine & Sports Medicine Rebrands as NefraHealth
10/02/2026
New Identity Reflects Patient-First Philosophy, Practice Growth Board-Certified Spine Surgeon Joins Growing Central Jersey Practice OLD BRIDGE, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Hassan Spine & Sports Medicine [...]
Tecan to host Analyst and Media Conference with Capital Markets Update on March 16, 2026
10/02/2026
Männedorf, Switzerland, February 10, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) will hold an Analyst and Media Conference on Monday, March 16, 2026, at 2:00 pm CET to present its full-year 2025 financial results [...]
Hyagen Medical Launches National FDA Compliance and Education Initiative to Strengthen Regenerative Medicine Standards
10/02/2026
FDA-aligned education and compliance for ethical stem cell and regenerative medicine practices Lehi, UT, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Hyagen Medical , a regulatory compliance and education company specializing in [...]
Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition
10/02/2026
ORLANDO, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCID: MAJI) , a clinical-stage biotechnology company specializing in proprietary exosome-based delivery systems, is pleased to announce a significant [...]
Press Release: Sanofi completes the acquisition of Dynavax
10/02/2026
Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition includes Dynavax’s adult [...]
Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
10/02/2026
WHO recognition of “etaroleucel” (CELZ-101) builds on prior “olastrocel” (CELZ-201) milestone, reinforcing platform credibility and supporting multi-program execution PHOENIX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Creative [...]

Pages